Copyright
©The Author(s) 2023.
World J Virol. Dec 25, 2023; 12(5): 296-308
Published online Dec 25, 2023. doi: 10.5501/wjv.v12.i5.296
Published online Dec 25, 2023. doi: 10.5501/wjv.v12.i5.296
Factors | HBeAg sero-positive | HBeAg sero-negative | ||||
High HBV DNA | Low HBV DNA | P value | High HBV DNA | Low HBV DNA | P value | |
Case n = 460 | Case n = 201 | Case n = 355 | Case n = 587 | |||
Demographic | ||||||
Age (yr) | 45 (36–59) | 50 (40–59) | 0.106 | 54 (45–61) | 55 (46–61) | 0.564 |
Male gender | 314 (68.2) | 137 (68.1) | 0.412 | 128 (56.6) | 93 (68.4) | 0.026 |
Laboratory tests | ||||||
FBG (mmol/L) | 4.83 (4.40–5.35) | 5.10 (4.60–5.90) | < 0.001 | 5.23 (4.73–6.20) | 5.28 (4.80–6.06) | 0.795 |
ALT (U/L) | 83.21 (43.45–190.62) | 51.60 (26.62–120.07) | < 0.001 | 53.00 (3200–127.00) | 27.60 (19.38–53.60) | < 0.001 |
AST (U/L) | 59.30 (38.01–130.1) | 46.85 (26.00–93.18) | < 0.001 | 46.50 (37.57–116.55) | 27.00 (20.72–46.47) | < 0.001 |
ALP (U/L) | 87.50 (67.98–117.09) | 90.18 (67.00–127.15) | 0.489 | 83.40 (65.20–111.90) | 74.00 (60.00–96.00) | < 0.001 |
γ-GGT (U/L) | 64.61 (33.50–139.92) | 68.25 (33.25–145.87) | 0.615 | 52.00 (21.90–115.69) | 69.6 (33.40–164.30) | < 0.001 |
LDH (U/L) | 195.00 (171.92–238.32) | 193.40 (167.37–228.97) | 0.38 | 197.00 (170.08–239.14) | 194.00 (169.00–222.39) | 0.077 |
Albumin (g/L) | 39.40 (32.81–43.36) | 40.30 (34.89–44.50) | 0.026 | 54.00 (45.00–61.50) | 43.90 (38.00–47.70) | < 0.001 |
Total bilirubin (µmol/L) | 17.90 (12.40–28.35) | 17.80 (13.21–32.52) | 0.751 | 17.20 (11.9–27.00) | 14.71 (11.08–22.47) | < 0.001 |
Bile acids (ug/mL) | 16.60 (8.01—38.77) | 16.50 (8.01–41.52) | 0.904 | 10.06 (4.98–27.50) | 7.07 (3.73–16.54) | < 0.001 |
Total cholesterol (mmol/L) | 4.16 (3.50–4.85) | 4.00 (3.30–4.83) | 0.674 | 4.22 (3.49–5.01) | 4.46 (3.71–5.15) | 0.019 |
Triglycerides (mmol/L) | 1.03 (0.73–1.44) | 1.08 (0.71–1.71) | 0.429 | 1.04 (0.73–1.41) | 1.14 (0.75–1.72) | 0.002 |
HDL-C (mmol/L) | 1.19 (0.90–1.43) | 1.08 (0.81–1.40) | 0.041 | 1.20 (0.92–1.44) | 1.12 (0.91–1.38) | 0.13 |
LDL-C (mmol/L) | 2.25 (1.76–2.90) | 2.41 (1.89–3.06) | 0.041 | 2.31 (1.72–2.87) | 2.54 (1.97–3.12) | < 0.001 |
apoA (g/L) | 1.17 (0.97–1.35) | 1.15 (0.92–1.30) | 0.204 | 1.21 (1.00–1.40) | 1.20 (1.04–1.41) | 0.624 |
apoB (g/L) | 0.85 (0.69–1.02) | 0.91 (0.70–1.12) | 0.01 | 0.83 (0.68–1.00) | 0.91 (0.74–1.09) | < 0.001 |
Steatosis | 11 (2.4) | 37 (18.4) | < 0.001 | 11 (3.0%) | 101 (17.2) | < 0.001 |
- Citation: Wang C, Gao XY, Han M, Jiang MC, Shi XY, Pu CW, Du X. Perilipin2 inhibits the replication of hepatitis B virus deoxyribonucleic acid by regulating autophagy under high-fat conditions. World J Virol 2023; 12(5): 296-308
- URL: https://www.wjgnet.com/2220-3249/full/v12/i5/296.htm
- DOI: https://dx.doi.org/10.5501/wjv.v12.i5.296